Skip to main content

Two decades after a patient died in his gene-therapy trial, Penn's Jim Wilson has a new approach — to be tested in babies

By The Philadelphia Inquirer  
   December 01, 2022

A startup that Wilson co-founded has received $65 million in new venture capital financing, the company said Wednesday.

Full story

Get the latest on healthcare leadership in your inbox.